Niagen Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAGE and other ETFs, options, and stocks.

About NAGE

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). 

CEO
Robert N. Fried
CEORobert N. Fried
Employees
117
Employees117
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
1999
Founded1999
Employees
117
Employees117

NAGE Key Statistics

Market cap
169.48M
Market cap169.48M
Price-Earnings ratio
17.72
Price-Earnings ratio17.72
Dividend yield
—
Dividend yield—
Average volume
614.42K
Average volume614.42K
High today
$2.15
High today$2.15
Low today
$2.12
Low today$2.12
Open price
$2.12
Open price$2.12
Volume
35.96K
Volume35.96K
52 Week high
$7.28
52 Week high$7.28
52 Week low
$2.04
52 Week low$2.04

Stock Snapshot

As of today, Niagen Bioscience(NAGE) shares are valued at $2.14. The company's market cap stands at 169.48M, with a P/E ratio of 17.72.

On 2026-11-13, Niagen Bioscience(NAGE) stock moved within a range of $2.12 to $2.15. With shares now at $2.14, the stock is trading +0.9% above its intraday low and -0.5% below the session's peak.

Trading activity shows a volume of 35.96K, compared to an average daily volume of 614.42K.

Over the past 52 weeks, Niagen Bioscience(NAGE) stock has traded between a high of $7.28 and a low of $2.04.

Over the past 52 weeks, Niagen Bioscience(NAGE) stock has traded between a high of $7.28 and a low of $2.04.

NAGE News

Investing.com 1d
Niagen Bioscience enables HSA/FSA payments for injection kit - Investing.com

...

Niagen Bioscience enables HSA/FSA payments for injection kit - Investing.com
TipRanks 1d
Niagen Bioscience announces partnership with Truemed

Niagen Bioscience (NAGE) announced that it has partnered with Truemed to provide qualified customers the option to purchase the Niagen At-Home Injection Kit usi...

Simply Wall St 2d
Niagen Bioscience's Shareholders Have More To Worry About Than Lackluster Earnings

Niagen Bioscience, Inc. ( ) recently posted soft earnings but shareholders didn't react strongly. We did some digging, and we believe that investors are missing...

Niagen Bioscience's Shareholders Have More To Worry About Than Lackluster Earnings

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own NAGE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.